FIELD: pharmacology.
SUBSTANCE: invention relates to the use of 3-n-butyl ketone isoindolin of the formula I
for the preparation of drugs for the prevention and treatment of cerebral infarction.
EFFECT: compound may be used in various dosage forms and gives great possibilities of clinical application.
7 cl, 5 dwg, 6 ex
Authors
Dates
2017-07-19—Published
2013-09-10—Filed